# CALGB-30610 (NCT00632853)

> Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00632853
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Alliance for Clinical Trials in Oncology
- Conditions: Lung Cancer
- Interventions: Standard Radiation Dose Therapy; cisplatin; etoposide; High Radiation Dose Therapy; carboplatin
- Enrollment: 731
- Primary outcome: Overall Survival Time

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- YouTube: 3
- X threads: 3
- Podcasts: 2

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=calgb-30610-nct00632853

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00632853", "email": "<work email>"}; the inbox owner confirms by the emailed link.